![Sandesh Seth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandesh Seth
Vorstandsvorsitzender bei
ACTINIUM PHARMACEUTICALS, INC.
Vermögen: 232 446 $ am 31.05.2026
Profil
Sandesh Seth is currently Chairman, Chief Executive & Financial Officer at Actinium Pharmaceuticals, Inc. since 2026 and Managing Partner at Jamess Capital Group LLC.
Former roles include Chairman at Relmada Therapeutics, Inc. from 2015 to 2017, Director at Actinium Pharmaceuticals, Inc., Director at Cactus Ventures, Inc. from 2012 to 2013, Lead Director at Camp Nine, Inc., Director at Relmada Therapeutics, Inc. from 2012 to 2014, and Head-Healthcare Investment Banking at Laidlaw & Co. (UK) Ltd. Education includes an MBA from New York University and an undergraduate degree from the University of Mumbai.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.10.2025 | 184.481 ( 0,59 % ) | 232 446 $ | 31.05.2026 |
Aktive Positionen von Sandesh Seth
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 09.06.2017 |
Jamess Capital Group LLC | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Sandesh Seth
| Unternehmen | Position | Ende |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Vorsitzender | 06.06.2017 |
Laidlaw & Co. (UK) Ltd.
 Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Provides investment advice | Corporate Officer/Principal | 01.07.2015 |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Direktor/Vorstandsmitglied | 18.04.2013 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Direktor/Vorstandsmitglied | 18.04.2013 |
Camp Nine, Inc.
 Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Operates as a clinical stage biopharmaceutical company | Direktor/Vorstandsmitglied | - |
Ausbildung von Sandesh Seth
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
38
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Camp Nine, Inc.
Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Provides investment advice | Finance |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for the treatment of acute and chronic pains | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Jamess Capital Group LLC | |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
